Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3751 AL 3765

Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders

Kandpal M, Indari O, Baral B, Jakhmola S, Tiwari D, Bhandari V, Pandey RK, Bala K, Sonawane A, Jha HC.

Metabolites. 2022 Nov 3;12(11):1064. doi: 10.3390/metabo12111064.

An app-based just-in-time-adaptive self-management intervention for care partners: The CareQOL feasibility pilot study

Carlozzi NE, Choi SW, Wu Z, Troost JP, Lyden AK, Miner JA, Graves CM, Wang J, Yan X, Sen S.

Rehabil Psychol. 2022 Nov;67(4):497-512. doi: 10.1037/rep0000472.

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons

Krach F, Stemick J, Boerstler T, Weiss A, Lingos I, Reischl S, Meixner H, Ploetz S, Farrell M, Hehr U, Kohl Z, Winner B, Winkler J.

Nat Commun. 2022 Nov 10;13(1):6797. doi: 10.1038/s41467-022-34419-x.

The Role of the Thioredoxin System in Brain Diseases

Bjørklund G, Zou L, Peana M, Chasapis CT, Hangan T, Lu J, Maes M.

Antioxidants (Basel). 2022 Oct 31;11(11):2161. doi: 10.3390/antiox11112161.

Insights into White Matter Defect in Huntington's Disease

Sun Y, Tong H, Yang T, Liu L, Li XJ, Li S.

Cells. 2022 Oct 26;11(21):3381. doi: 10.3390/cells11213381.

Role of SUMOylation in Neurodegenerative Diseases

Mandel N, Agarwal N.

Cells. 2022 Oct 27;11(21):3395. doi: 10.3390/cells11213395.

The DNA Methylation in Neurological Diseases

Younesian S, Yousefi AM, Momeny M, Ghaffari SH, Bashash D.

Cells. 2022 Oct 31;11(21):3439. doi: 10.3390/cells11213439.

Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders

Zayed MA, Sultan S, Alsaab HO, Yousof SM, Alrefaei GI, Alsubhi NH, Alkarim S, Al Ghamdi KS, Bagabir SA, Jana A, Alghamdi BS, Atta HM, Ashraf GM.

Cells. 2022 Nov 2;11(21):3476. doi: 10.3390/cells11213476.

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's Disease

Pellegrini M, Bergonzoni G, Perrone F, Squitieri F, Biagioli M.

Genes (Basel). 2022 Nov 3;13(11):2017. doi: 10.3390/genes13112017.

Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies

Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH.

Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841.

Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation?

Ruggiero M, Calvello R, Porro C, Messina G, Cianciulli A, Panaro MA.

Int J Mol Sci. 2022 Oct 26;23(21):12958. doi: 10.3390/ijms232112958.

Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease

Sterling KG, Dodd GK, Alhamdi S, Asimenios PG, Dagda RK, De Meirleir KL, Hudig D, Lombardi VC.

Int J Mol Sci. 2022 Nov 1;23(21):13328. doi: 10.3390/ijms232113328.

Approaches to Mitigate Mitochondrial Dysfunction in Sensorineural Hearing Loss

Okur MN, Djalilian HR.

Ann Biomed Eng. 2022 Dec;50(12):1762-1770. doi: 10.1007/s10439-022-03103-y. Epub 2022 Nov 11.

Treatment-resistant diabetic chorea manifesting with psychiatric symptoms: a case report

Miyauchi T, Yoshii M, Oshima T, Tomotsune K, Tomiyasu K.

Neurocase. 2022 Oct;28(5):432-438. doi: 10.1080/13554794.2022.2145906. Epub 2022 Nov 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias